Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
Valentina Comunanza(Istituti di Ricovero e Cura a Carattere Scientifico), Federico Bussolino(Candiolo Cancer Institute)
Cited by 91
Related Papers
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
|Journal of Clinical Investigation|2012|184
Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor.
|The Journal of Experimental Medicine|1995|99
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages
|The Journal of Immunology|2012|81
Synergism Between Platelet Activating Factor and C-C Chemokines for Arachidonate Release in Human Monocytes
|Biochemical and Biophysical Research Communications|1994|40